tiprankstipranks
Praxis Precision Medicines, Inc. (PRAX)
NASDAQ:PRAX
US Market
Want to see PRAX full AI Analyst Report?

Praxis Precision Medicines (PRAX) Stock Forecast & Price Target

997 Followers
See the Price Targets and Ratings of:

PRAX Analyst Ratings

Strong Buy
17Ratings
Strong Buy
15 Buy
1 Hold
1 Sell
Based on 17 analysts giving stock ratings to
Praxis
Precision Medicines
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

PRAX Stock 12 Month Forecast

Average Price Target

$623.24
▲(81.97% Upside)
Based on 17 Wall Street analysts offering 12 month price targets for Praxis Precision Medicines in the last 3 months. The average price target is $623.24 with a high forecast of $1,201.00 and a low forecast of $162.00. The average price target represents a 81.97% change from the last price of $342.50.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"38":"$38","329":"$329","620":"$620","911":"$911","1202":"$1,202"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1201,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$1.20K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":623.2352941176471,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$623.24</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":162,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$162.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[38,329,620,911,1202],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,335.16,401.76307692307694,468.36615384615385,534.9692307692308,601.5723076923077,668.1753846153846,734.7784615384614,801.3815384615384,867.9846153846154,934.5876923076924,1001.1907692307691,1067.793846153846,1134.396923076923,{"y":1201,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,335.16,357.3196380090498,379.47927601809954,401.6389140271493,423.7985520361991,445.9581900452489,468.1178280542987,490.2774660633484,512.4371040723981,534.5967420814479,556.7563800904977,578.9160180995475,601.0756561085973,{"y":623.2352941176471,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,335.16,321.84000000000003,308.52000000000004,295.20000000000005,281.88,268.56,255.24,241.92000000000002,228.60000000000002,215.28,201.96,188.64000000000001,175.32,{"y":162,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":39.82,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":43.17,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":54.09,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":44.94,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":53.02,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":198.76,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":184.56,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 55,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":294.74,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 51,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":309.11,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 51,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":330.59,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":319.28,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":324.2,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":335.16,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$1,201Average Price Target$623.24Lowest Price Target$162.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TD Cowen Analyst forecast on PRAX
TD Cowen
TD Cowen
$554$510
Buy
48.91%
Upside
Assigned
06/02/26
TD Cowen Sticks to Its Buy Rating for Praxis Precision Medicines (PRAX)
Needham Analyst forecast on PRAX
Needham
Needham
$537
Buy
56.79%
Upside
Reiterated
06/02/26
Buy Rating Reaffirmed as Higher Relutrigine Pricing Assumptions Offset Vormatrigine Setback; $537 Price Target Maintained
Guggenheim Analyst forecast on PRAX
Guggenheim
Guggenheim
$800
Buy
133.58%
Upside
Reiterated
06/02/26
Guggenheim Sticks to Its Buy Rating for Praxis Precision Medicines (PRAX)
Piper Sandler Analyst forecast on PRAX
Piper Sandler
Piper Sandler
$1,200
Buy
250.36%
Upside
Reiterated
06/02/26
Piper Sandler Remains a Buy on Praxis Precision Medicines (PRAX)
Oppenheimer Analyst forecast on PRAX
Oppenheimer
Oppenheimer
$750$650
Buy
89.78%
Upside
Assigned
06/02/26
Praxis Precision price target lowered to $650 from $750 at OppenheimerPraxis Precision price target lowered to $650 from $750 at Oppenheimer
H.C. Wainwright Analyst forecast on PRAX
H.C. Wainwright
H.C. Wainwright
$1,245$1,201
Buy
250.66%
Upside
Reiterated
06/02/26
Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (NASDAQ: PRAX), Compass Therapeutics (NASDAQ: CMPX) and Tenax Therapeutics (NASDAQ: TENX)
Wedbush
$166$162
Sell
-52.70%
Downside
Reiterated
06/02/26
Praxis Precision price target lowered to $162 from $166 at WedbushPraxis Precision price target lowered to $162 from $166 at Wedbush
Deutsche Bank  Analyst forecast on PRAX
Deutsche Bank
Deutsche Bank
$420$374
Buy
9.20%
Upside
Reiterated
06/02/26
Praxis Precision price target lowered to $374 from $420 at Deutsche BankPraxis Precision price target lowered to $374 from $420 at Deutsche Bank
JonesTrading Analyst forecast on PRAX
JonesTrading
JonesTrading
$441
Buy
28.76%
Upside
Reiterated
06/02/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Heron Therapeutics (NASDAQ: HRTX) and Praxis Precision Medicines (NASDAQ: PRAX)
Truist Financial Analyst forecast on PRAX
Truist Financial
Truist Financial
$715$616
Buy
79.85%
Upside
Assigned
06/02/26
Praxis Precision Medicines (PRAX) Gets a Buy from Truist Financial
BTIG
$843$810
Buy
136.50%
Upside
Reiterated
06/02/26
Yazdi Maintains Buy on Praxis, Trims Price Target to $810 as Vormatrigine Outlook Softens but Core Pipeline Thesis Remains Intact
LifeSci Capital Analyst forecast on PRAX
LifeSci Capital
LifeSci Capital
$795$731
Buy
113.43%
Upside
Reiterated
06/02/26
Praxis Precision Medicines (PRAX) Receives a Buy from LifeSci Capital
Robert W. Baird Analyst forecast on PRAX
Robert W. Baird
Robert W. Baird
$433$400
Buy
16.79%
Upside
Reiterated
06/02/26
Praxis Precision price target lowered to $400 from $433 at BairdPraxis Precision price target lowered to $400 from $433 at Baird
Wells Fargo Analyst forecast on PRAX
Wells Fargo
Wells Fargo
$305$323
Hold
-5.69%
Downside
Reiterated
06/01/26
Wells Fargo Sticks to Its Hold Rating for Praxis Precision Medicines (PRAX)
Raymond James Analyst forecast on PRAX
Raymond James
Raymond James
$815
Buy
137.96%
Upside
Initiated
04/08/26
Praxis Precision initiated with a Strong Buy at Raymond JamesPraxis Precision initiated with a Strong Buy at Raymond James
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TD Cowen Analyst forecast on PRAX
TD Cowen
TD Cowen
$554$510
Buy
48.91%
Upside
Assigned
06/02/26
TD Cowen Sticks to Its Buy Rating for Praxis Precision Medicines (PRAX)
Needham Analyst forecast on PRAX
Needham
Needham
$537
Buy
56.79%
Upside
Reiterated
06/02/26
Buy Rating Reaffirmed as Higher Relutrigine Pricing Assumptions Offset Vormatrigine Setback; $537 Price Target Maintained
Guggenheim Analyst forecast on PRAX
Guggenheim
Guggenheim
$800
Buy
133.58%
Upside
Reiterated
06/02/26
Guggenheim Sticks to Its Buy Rating for Praxis Precision Medicines (PRAX)
Piper Sandler Analyst forecast on PRAX
Piper Sandler
Piper Sandler
$1,200
Buy
250.36%
Upside
Reiterated
06/02/26
Piper Sandler Remains a Buy on Praxis Precision Medicines (PRAX)
Oppenheimer Analyst forecast on PRAX
Oppenheimer
Oppenheimer
$750$650
Buy
89.78%
Upside
Assigned
06/02/26
Praxis Precision price target lowered to $650 from $750 at OppenheimerPraxis Precision price target lowered to $650 from $750 at Oppenheimer
H.C. Wainwright Analyst forecast on PRAX
H.C. Wainwright
H.C. Wainwright
$1,245$1,201
Buy
250.66%
Upside
Reiterated
06/02/26
Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (NASDAQ: PRAX), Compass Therapeutics (NASDAQ: CMPX) and Tenax Therapeutics (NASDAQ: TENX)
Wedbush
$166$162
Sell
-52.70%
Downside
Reiterated
06/02/26
Praxis Precision price target lowered to $162 from $166 at WedbushPraxis Precision price target lowered to $162 from $166 at Wedbush
Deutsche Bank  Analyst forecast on PRAX
Deutsche Bank
Deutsche Bank
$420$374
Buy
9.20%
Upside
Reiterated
06/02/26
Praxis Precision price target lowered to $374 from $420 at Deutsche BankPraxis Precision price target lowered to $374 from $420 at Deutsche Bank
JonesTrading Analyst forecast on PRAX
JonesTrading
JonesTrading
$441
Buy
28.76%
Upside
Reiterated
06/02/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Heron Therapeutics (NASDAQ: HRTX) and Praxis Precision Medicines (NASDAQ: PRAX)
Truist Financial Analyst forecast on PRAX
Truist Financial
Truist Financial
$715$616
Buy
79.85%
Upside
Assigned
06/02/26
Praxis Precision Medicines (PRAX) Gets a Buy from Truist Financial
BTIG
$843$810
Buy
136.50%
Upside
Reiterated
06/02/26
Yazdi Maintains Buy on Praxis, Trims Price Target to $810 as Vormatrigine Outlook Softens but Core Pipeline Thesis Remains Intact
LifeSci Capital Analyst forecast on PRAX
LifeSci Capital
LifeSci Capital
$795$731
Buy
113.43%
Upside
Reiterated
06/02/26
Praxis Precision Medicines (PRAX) Receives a Buy from LifeSci Capital
Robert W. Baird Analyst forecast on PRAX
Robert W. Baird
Robert W. Baird
$433$400
Buy
16.79%
Upside
Reiterated
06/02/26
Praxis Precision price target lowered to $400 from $433 at BairdPraxis Precision price target lowered to $400 from $433 at Baird
Wells Fargo Analyst forecast on PRAX
Wells Fargo
Wells Fargo
$305$323
Hold
-5.69%
Downside
Reiterated
06/01/26
Wells Fargo Sticks to Its Hold Rating for Praxis Precision Medicines (PRAX)
Raymond James Analyst forecast on PRAX
Raymond James
Raymond James
$815
Buy
137.96%
Upside
Initiated
04/08/26
Praxis Precision initiated with a Strong Buy at Raymond JamesPraxis Precision initiated with a Strong Buy at Raymond James
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Praxis Precision Medicines

3 Months
Yasmeen RahimiPiper Sandler
Success Rate
17/22 ratings generated profit
77%
Average Return
+72.39%
Copying Yasmeen Rahimi's trades and holding each position for 3 Months would result in 77.27% of your transactions generating a profit, with an average return of +72.39% per trade.
1 Year
Douglas TsaoH.C. Wainwright
Success Rate
19/28 ratings generated profit
68%
Average Return
+182.21%
Copying Douglas Tsao's trades and holding each position for 1 Year would result in 67.86% of your transactions generating a profit, with an average return of +182.21% per trade.
2 Years
Yasmeen RahimiPiper Sandler
Success Rate
19/22 ratings generated profit
86%
Average Return
+380.71%
Copying Yasmeen Rahimi's trades and holding each position for 2 Years would result in 86.36% of your transactions generating a profit, with an average return of +380.71% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

PRAX Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
30
23
28
27
33
Buy
21
8
8
6
7
Hold
2
2
4
2
3
Sell
0
0
0
1
2
Strong Sell
3
2
1
0
0
total
56
35
41
36
45
In the current month, PRAX has received 40 Buy Ratings, 3 Hold Ratings, and 2 Sell Ratings. PRAX average Analyst price target in the past 3 months is 623.24.
Each month's total comprises the sum of three months' worth of ratings.

PRAX Financial Forecast

PRAX Earnings Forecast

Next quarter’s earnings estimate for PRAX is -$3.68 with a range of -$5.33 to -$3.04. The previous quarter’s EPS was -$3.20. PRAX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year PRAX has Performed in-line its overall industry.
Next quarter’s earnings estimate for PRAX is -$3.68 with a range of -$5.33 to -$3.04. The previous quarter’s EPS was -$3.20. PRAX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year PRAX has Performed in-line its overall industry.

PRAX Sales Forecast

Next quarter’s sales forecast for PRAX is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. PRAX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year PRAX has Performed in-line its overall industry.
Next quarter’s sales forecast for PRAX is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. PRAX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year PRAX has Performed in-line its overall industry.

PRAX Stock Forecast FAQ

What is PRAX’s average 12-month price target, according to analysts?
Based on analyst ratings, Praxis Precision Medicines, Inc.’s 12-month average price target is 623.24.
    What is PRAX’s upside potential, based on the analysts’ average price target?
    Praxis Precision Medicines, Inc. has 81.97% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is PRAX a Buy, Sell or Hold?
          Praxis Precision Medicines, Inc. has a consensus rating of Strong Buy which is based on 15 buy ratings, 1 hold ratings and 1 sell ratings.
            What is Praxis Precision Medicines, Inc.’s price target?
            The average price target for Praxis Precision Medicines, Inc. is 623.24. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $1,201.00 ,the lowest forecast is $162.00. The average price target represents 81.97% Increase from the current price of $342.5.
              What do analysts say about Praxis Precision Medicines, Inc.?
              Praxis Precision Medicines, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 17 Wall Streets Analysts.
                How can I buy shares of PRAX?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.